Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Biotechnology

Biohaven Pharmaceuticals

Biohaven Pharmaceuticals' headquarters in New Haven, CT, United States

Vlad Coric

Matthew Buten

Tova Gardin

Kimberly Gentile

Robert Croop

Bruce D. Car

Cliff Bechtold

John Tilton

Javier Gonzalez

Bruce Car

Elizabeth Dierks

Bavani Shankar

Brian Lestini

John M.

Jim Engelhart

Michael Bozik

St John Donnie McGrath

Warren Volles

Gregory H. Bailey

John W. Childs

Robert J. Hugin

Michael T. Heffernan

Irina A. Antonijevic

Gregory Hebrank

This department focuses on selling neuroscience-related products and solutions to clients.

Neuroscience Sales

The Leadership Team at Biohaven Pharmaceuticals is responsible for setting the strategic direction and oversight of the company’s research and development initiatives focused on the glutamatergic system. Comprising top executives from various disciplines, including R&D, medical affairs, and commercial strategy, the team collaborates to drive innovative drug development, ensure regulatory compliance, and establish partnerships that enhance the company's market position and growth potential. Their efforts are crucial in advancing clinical programs and bringing novel therapies to patients suffering from neurological disorders.

Leadership Team

The Clinical Operations Team at Biohaven Pharmaceuticals is responsible for the planning, execution, and management of clinical trials focused on developing therapeutics targeting the glutamatergic system. This team ensures compliance with regulatory standards, coordinates clinical supply chain logistics, and oversees quality assurance to facilitate the successful advancement of clinical stage compounds from initiation through completion. Additionally, they collaborate closely with cross-functional teams to streamline operations and enhance the efficiency of clinical development processes.

Clinical Operations Team

The Research and Development Team at Biohaven Pharmaceuticals focuses on the discovery and development of innovative therapies targeting the glutamatergic system. Comprised of experts in various scientific and medical disciplines, the team conducts preclinical and clinical research, designs and analyzes experiments, and ensures compliance with regulatory standards to advance clinical-stage compounds from concept to treatment. Their collaborative efforts aim to enhance understanding of neurological disorders and pave the way for effective new therapies.

Research and Development Team

This department oversees and manages all aspects of clinical operations, ensuring the efficient conduct of clinical trials and regulatory compliance.

Clinical Operations

This department focuses on the study and application of neuroscience, providing expertise and support in related projects and research.

Neuroscience Division

��

Biohaven Pharmaceuticals

Org chart

Board & advisors

Teams

Neuroscience Sales

Leadership Team

Clinical Operations Team

Research and Development Team

Clinical Operations

Neuroscience Division

Offices

��������

Biohaven Pharmaceuticals

Org chart

Board & advisors

Teams

Neuroscience Sales

Leadership Team

Clinical Operations Team

Research and Development Team

Clinical Operations

Neuroscience Division

Offices

Related companies

��